Where Global Innovation
and Capital Meet

Passage Bio packs in another $110m

Sep 5, 2019 • Robert Lavine

University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.

US-based, University of Pennsylvania-linked genetic medicine developer Passage Bio completed a $110m series B round yesterday led by Access Biotechnology, the life sciences investment vehicle for diversified conglomerate Access Industries.
Lilly Asia Ventures, a corporate venturing subsidiary of pharmaceutical firm Eli Lilly, also took part, as did OrbiMed, Frazier Healthcare Partners, Versant Ventures, New Leaf Venture Partners, Vivo Capital, Boxer Capital, Highline Capital Management, Logos Capital and Sphera Funds Management.
Founded in 2018, Passage Bio is developing therapies…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

University of Notre Dame tries new, supersized approach to creating spinouts

A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.

University of Tokyo investment arm forms deeptech fund

University of Tokyo’s third investment fund reached a first close with capital from Tokyu Land and the Tokyo Metropolitan Government.

Rensselaer Polytechnic Institute to form $10m investment unit

The university’s new unit, which includes incubator, startup fund and brain trust, will be led by assistant vice president Joshua Espinosa.

Events

GCV Institute: Landing the Value of Corporate Venturing

May 6 -
May 9, 2024
Online

Find out more All events

Events

Webinar: CVCs and the art of the follow-on

May 8, 2024
Online

Find out more All events

Events

GCV Institute: CVC Investment Programs

May 21 -
May 22, 2024
Online

Find out more All events

Events

GCV Symposium 2024

Jun 24 -
Jun 26, 2024
London (UK)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.